INTEGRATED BIOPHARMA INC (INBP)
About INTEGRATED BIOPHARMA INC
INTEGRATED BIOPHARMA INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2018
- $43.7M
- Net income
- $808.0K
- Total assets
- $24.9M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Integrated Biopharma Inc (INBP) Stock Price
- Profitable — net income of $808.0K in FY2018.
- Trading 58% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review INTEGRATED BIOPHARMA INC.
Write a review
Integrated Biopharma Inc: frequently asked questions
Is Integrated Biopharma Inc an American company?
Integrated Biopharma Inc is a US-based company headquartered in Hillside, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Integrated Biopharma Inc headquartered?
Integrated Biopharma Inc is headquartered in Hillside, New Jersey, United States.
Is Integrated Biopharma Inc publicly traded?
Yes — Integrated Biopharma Inc is a publicly traded company. Its stock trades under the ticker symbol INBP on the OTC.
What does Integrated Biopharma Inc do?
Integrated Biopharma Inc is an American Pharmaceuticals company in the Health & Beauty sector.
